27.86
Mineralys Therapeutics Inc 주식(MLYS)의 최신 뉴스
Mineralys Therapeutics launches $175M public offering - MSN
Mineralys Therapeutics (NASDAQ:MLYS) Insider David Malcom Rodman Sells 2,171 Shares - MarketBeat
Biotech Mineralys offers 4-year stock awards to new hires - Stock Titan
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Mineralys Therapeutics, Inc. $MLYS Shares Sold by Candriam S.C.A. - MarketBeat
Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 60% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Mineralys Therapeutics Sees Unusually Large Options Volume (NASDAQ:MLYS) - MarketBeat
Panic Selling: How sensitive is Mineralys Therapeutics Inc to inflationJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Mineralys Therapeutics (MLYS) to Release Earnings on Wednesday - MarketBeat
Profit Review: How sensitive is Mineralys Therapeutics Inc to inflation2025 Momentum Check & Safe Entry Trade Reports - baoquankhu1.vn
Mineralys Therapeutics Reports Positive Phase 2 Trial Results for Lorundrostat in Hypertension and CKD - MSN
Mineralys Therapeutics (MLYS) Files Lorundrostat NDA Following Positive Clinical Milestones - Finviz
11 Best High Short Interest Stocks With Biggest Upside Potential - Insider Monkey
Mineralys Awards New Hire Stock Option as Hypertension Pipeline Advances - MSN
Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Uncovering a 53.98% Potential Upside in Biotech - DirectorsTalk Interviews
What is HC Wainwright's Forecast for MLYS FY2030 Earnings? - MarketBeat
Insider Trends: How sensitive is Mineralys Therapeutics Inc to inflationWeekly Trade Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Mineralys Therapeutics to Announce Q2 Financial Results on August 12 - MSN
Aug EndMonth: Will CMPS benefit from rate cutsJuly 2025 Pullbacks & AI Powered Market Entry Ideas - baoquankhu1.vn
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Avoiding Lag: Real-Time Signals in (MLYS) Movement - Stock Traders Daily
Mineralys Therapeutics Inc call volume above normal and directionally bullish - TipRanks
Mineralys Therapeutics’ Earnings Call Highlights Positive Outlook - MSN
Relative Strength Alert For Mineralys Therapeutics - Nasdaq
Rodman sells Mineralys (MLYS) shares for $13,353 - Investing.com
Rodman sells Mineralys (MLYS) shares for $13,353 By Investing.com - Investing.com Nigeria
David Malcom Rodman Sells 416 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat
Fed Watch: What is Mineralys Therapeutics Incs revenue forecast2025 Market Overview & Smart Swing Trading Alerts - baoquankhu1.vn
Activity Recap: Is EKSO a potential multi baggerAnalyst Upgrade & Fast Moving Stock Watchlists - baoquankhu1.vn
Are Mineralys Therapeutics’ (MLYS) Executive Stock Plans Aligned With Lorundrostat’s Emerging Investment Story? - Sahm
Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 7,709 Shares of Stock - MarketBeat
David Malcom Rodman Sells 11,367 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat
Sell Signal: Is Mineralys Therapeutics Inc. part of any major index2025 Earnings Impact & Free High Return Stock Watch Alerts - baoquankhu1.vn
Mineralys Therapeutics CEO Congleton sells $529k in MLYS stock By Investing.com - Investing.com Nigeria
Mineralys Therapeutics (NASDAQ:MLYS) CEO Sells $529,618.32 in Stock - MarketBeat
Levy, Mineralys Therapeutics CFO, sells $345k in MLYS stock By Investing.com - Investing.com Canada
Mineralys Therapeutics MLYS officer sells $277k in stock By Investing.com - Investing.com South Africa
Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells $72,195.90 in Stock - MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells $205,167.36 in Stock - MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) CFO Sells $345,762.12 in Stock - MarketBeat
Levy, Mineralys Therapeutics CFO, sells $345k in MLYS stock - Investing.com
Mineralys Therapeutics MLYS officer sells $277k in stock - Investing.com
Buybacks Report: Will Mineralys Therapeutics Inc outperform tech stocksQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Patterns Watch: Whats Mineralys Therapeutics Incs historical returnJuly 2025 Rallies & Safe Capital Investment Plans - baoquankhu1.vn
Mineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch - TipRanks
Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Unveiling a 54% Upside Potential in the Biotech Arena - DirectorsTalk Interviews
Discipline and Rules-Based Execution in MLYS Response - Stock Traders Daily
Trend Recap: Whats the RSI of Mineralys Therapeutics Inc stockJuly 2025 PostEarnings & Reliable Breakout Forecasts - baoquankhu1.vn
Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - ADVFN
Will Mineralys Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Outlook & Risk Adjusted Buy/Sell Alerts - Улправда
Mineralys Therapeutics (MLYS) Stock Analysis Report | Financials & Insights - Benzinga España
자본화:
|
볼륨(24시간):